Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy

Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy

Abstract Background Sarcomatoid carcinoma is a rare, high-grade malignancy with epithelial and mesenchymal components. It may be a good candidate for immunotherapy because it is associated with overexpression of programmed cell death ligand 1. Sarcomatoid urothelial carcinoma (UC) of the upper urina...

Full description

Bibliographic Details
Main Authors: Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Urology
Subjects:
Sarcomatoid
Urothelial carcinoma
Renal pelvis
Immunotherapy
Programmed cell death ligand 1
Cytotoxic T-lymphocyte antigen 4
Online Access:https://doi.org/10.1186/s12894-023-01210-z

Internet

https://doi.org/10.1186/s12894-023-01210-z

Similar Items